Kinetics of CA19-9 Decline in a Phase III Study of Liposomal Irinotecan, Oxaliplatin, 5-Fluorouracil/Leucovorin (NALIRIFOX) or Nab-Paclitaxel Plus Gemcitabine (Gem+NabP)in Patients Who Have Not Previously Received Chemotherapy for Metastatic Adenocarcinoma of the Pancreas (NAPOLI 3)
5-Fluorouracil;Gemcitabine;Leucovorin;Liposomal Irinotecan;Nab-Paclitaxel;Oxaliplatin
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Kinetics of CA19-9 Decline in a Phase III Study of Liposomal Irinotecan, Oxaliplatin, 5-Fluorouracil/Leucovorin (NALIRIFOX) or Nab-Paclitaxel Plus Gemcitabine (Gem+NabP)in Patients Who Have Not Previously Received Chemotherapy for Metastatic Adenocarcinoma of the Pancreas (NAPOLI 3) ### Output: 5-Fluorouracil;Gemcitabine;Leucovorin;Liposomal Irinotecan;Nab-Paclitaxel;Oxaliplatin